Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1986 Oct;61(10):1027–1029. doi: 10.1136/adc.61.10.1027

Erythromycin versus tetracycline for treatment of Mediterranean spotted fever.

T Muñoz-Espin, P López-Parés, E Espejo-Arenas, B Font-Creus, I Martinez-Vila, J Travería-Casanova, F Segura-Porta, F Bella-Cueto
PMCID: PMC1777969  PMID: 3535687

Abstract

Eighty one children aged between 1 and 13 years participated in a randomised comparative trial of tetracycline hydrochloride and erythromycin stearate for treatment of Mediterranean spotted fever. Both therapeutic regimens proved effective, but in patients treated with tetracycline both clinical symptoms and fever disappeared significantly more quickly. Likewise, when those patients who began treatment within the first 72 hours of illness are considered the febrile period had a significantly shorter duration in the group treated with tetracycline. One patient was switched to tetracycline because there was no improvement of clinical manifestations, with persistence of fever, myalgias, and prostration, after receiving eight days of treatment with erythromycin. These results suggest that tetracyclines are superior to erythromycin in the treatment of Mediterranean spotted fever.

Full text

PDF
1027

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Font-Creus B., Bella-Cueto F., Espejo-Arenas E., Vidal-Sanahuja R., Muñoz-Espin T., Nolla-Salas M., Casagran-Borrell A., Mercade-Cuesta J., Segura-Porta F. Mediterranean spotted fever: a cooperative study of 227 cases. Rev Infect Dis. 1985 Sep-Oct;7(5):635–642. doi: 10.1093/clinids/7.5.635. [DOI] [PubMed] [Google Scholar]
  2. Grossman E. R., Walchek A., Freedman H. Tetracyclines and permanent teeth: the relation between dose and tooth color. Pediatrics. 1971 Mar;47(3):567–570. [PubMed] [Google Scholar]
  3. Lambert M., Dugernier T., Bigaignon G., Rahier J., Piot P. Mediterranean spotted fever in Belgium. Lancet. 1984 Nov 3;2(8410):1038–1038. doi: 10.1016/s0140-6736(84)91133-4. [DOI] [PubMed] [Google Scholar]
  4. Moraga F. A., Martinez-Roig A., Alonso J. L., Boronat M., Domingo F. Boutonneuse fever. Arch Dis Child. 1982 Feb;57(2):149–151. doi: 10.1136/adc.57.2.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Raoult D., Gallais H., Ottomani A., Resch J. P., Tichadou D., De Micco P., Casanova P. La forme maligne de la fièvre boutonneuse méditerranéenne. Six observations. Presse Med. 1983 Oct 29;12(38):2375–2378. [PubMed] [Google Scholar]
  6. Raoult D., Kohler J. L., Gallais H., De Micco P., Rousseau S., Casanova P. Rickettsiose mortelle. Nouv Presse Med. 1982 Feb 20;11(8):607–607. [PubMed] [Google Scholar]
  7. Rhodes K. H., Johnson C. M. Antibiotic therapy for severe infections in infants and children. Mayo Clin Proc. 1983 Mar;58(3):158–164. [PubMed] [Google Scholar]
  8. Scaffidi L., Mansueto S. La febbre bottonosa nella pratica clinica. Minerva Med. 1981 Sep 1;72(31):2071–2078. [PubMed] [Google Scholar]
  9. Schlaeffer F., Lederer K., Mates S. M. Mediterranean spotted fever in an American woman. Arch Intern Med. 1985 Sep;145(9):1733–1734. [PubMed] [Google Scholar]
  10. Segura F., Font B. Resurgence of Mediterranean spotted fever in Spain. Lancet. 1982 Jul 31;2(8292):280–280. doi: 10.1016/s0140-6736(82)90369-5. [DOI] [PubMed] [Google Scholar]
  11. Staszewski S., Helm E. B., Stille W. Autochthonic Mediterranean spotted fever in West Germany. Lancet. 1984 Dec 22;2(8417-8418):1466–1466. doi: 10.1016/s0140-6736(84)91652-0. [DOI] [PubMed] [Google Scholar]
  12. Wisseman C. L., Jr, Waddell A. D., Walsh W. T. In vitro studies of the action of antibiotics on Rickettsia prowazeki by two basic methods of cell culture. J Infect Dis. 1974 Dec;130(6):564–574. doi: 10.1093/infdis/130.6.564. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES